Researchers have identified the protein GLT-1 as the neurotransmitter glutamate transporter in the brain that is related to cortical spreading depression, a pathological condition that underlies migraines. The researchers found that mice lacking GLT-1, but not other glutamate receptors, were more susceptible to cortical spreading depression than were controls. GLT-1 might therefore be a potential target for migraine therapy.
from Latest Science News -- ScienceDaily https://ift.tt/2EbRR9P
via IFTTT
Thursday, September 17, 2020
Potential target identified for migraine therapy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment